Please see our guidance before completing the above form.
You may also find it of benefit to review the full list of questions, which includes some guidance, before completing the form.
Please liaise with your IT department to ensure you can save PDFs before completing the form.
The MHRA has created a new international recognition route for medicines utilising pre-existing approvals from Australia, Canada, the European Union, Japan, Switzerland, Singapore and the United States. This new framework will support patients in the UK with expedited access to safe and effective medicines that have been approved by trusted regulatory partners. From 1 January 2024, international recognition will sit alongside the MHRA’s current national procedures.
The MHRA webinar provided potential applicants with the opportunity to increase their knowledge and understanding of the guidance on the International Recognition Procedure.